Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 302

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study

Open access
Duray, Gabor Z., Ritter, Philippe, El-Chami, Mikhael, Narasimhan, Calambur, Omar, Razali, Tolosana, Jose M., Zhang, Shu, Soejima, Kyoko, Steinwender, Clemens, Rapallini, Leonardo, Cicic, Aida, Fagan, Dedra H., Liu, Shufeng, Reynolds, Dwight·2017·Heart Rhythm

Abstract

BACKGROUND: Early performance of the Micra transcatheter pacemaker from the global clinical trial reported a 99.2% implant success rate, low and stable pacing capture thresholds, and a low (4.0%) rate of major complications up to 6 months. OBJECTIVE: The purpose of this report was to describe the prespecified long-term safety objective of Micra at 12 months and electrical performance through 24 months. METHODS: The Micra Transcatheter Pacing Study was a prospective single-arm study designed to assess the safety and efficacy of the Micra VVIR leadless/intracardiac pacemaker. Enrolled patients met class I or II guideline recommendations for de novo ventricular pacing. The long-term safety objective was freedom from a system- or procedure-related major complication at 12 months. A predefined historical control group of 2667 patients with transvenous pacemakers was used to compare major complication rates. RESULTS: The long-term safety objective was achieved with a freedom from major complication rate of 96.0% at 12 months (95% confidence interval 94.2%-97.2%; P < .0001 vs performance goal). The risk of major complications for patients with Micra (N = 726) was 48% lower than that for patients with transvenous systems through 12 months postimplant (hazard ratio 0.52; 95% confidence interval 0.35-0.77; P = .001). Across subgroups of age, sex, and comorbidities, Micra reduced the risk of major complications compared to transvenous systems. Electrical performance was excellent through 24 months, with a projected battery longevity of 12.1 years. CONCLUSION: Long-term performance of the Micra transcatheter pacemaker remains consistent with previously reported data. Few patients experienced major complications through 12 months of follow-up, and all patient subgroups benefited as compared to transvenous pacemaker historical control group.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.hrthm.2017.01.035

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 12

  1. Udo, 2012, Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study, Heart Rhythm, 9, 728, 10.1016/j.hrthm.2011.12.014 · DOI · Paper page
  2. Reddy, 2015, Percutaneous implantation of an entirely intracardiac leadless pacemaker, N Engl J Med, 373, 1125, 10.1056/NEJMoa1507192 · DOI · Paper page
  3. Reynolds, 2016, A leadless intracardiac transcatheter pacing system, N Engl J Med, 374, 533, 10.1056/NEJMoa1511643 · DOI · Paper page
  4. Ritter, 2015, Micra Transcatheter Pacing Study Group. The rationale and design of the Micra Transcatheter Pacing Study: safety and efficacy of a novel miniaturized pacemaker, Europace, 17, 807, 10.1093/europace/euv026 · DOI
  5. Zipes, 2006, J Am Coll Cardiol, 48, e247, 10.1016/j.jacc.2006.07.010 · DOI · Paper page
  6. Soejima, 2016, Safety evaluation of a leadless transcatheter pacemaker for magnetic resonance imaging use, Heart Rhythm, 13, 2056, 10.1016/j.hrthm.2016.06.032 · doi:10.1016/j.hrthm.2016.06.032
  7. Ritter, 2015, Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study, Eur Heart J, 36, 2510, 10.1093/eurheartj/ehv214 · DOI
  8. Hauser, 2007, Clinical experience with pacemaker pulse generators and transvenous leads: an 8-year prospective multicenter study, Heart Rhythm, 4, 154, 10.1016/j.hrthm.2006.10.009 · DOI · Paper page
  9. Senaratne, 2006, Pacemaker longevity: are we getting what we are promised?, Pacing Clin Electrophysiol, 29, 1044, 10.1111/j.1540-8159.2006.00497.x · DOI
  10. Tarakji, 2016, Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT), Am Heart J, 180, 12, 10.1016/j.ahj.2016.06.010 · DOI
  11. Baddour, 2010, Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association, Circulation, 121, 458, 10.1161/CIRCULATIONAHA.109.192665 · DOI · Paper page
  12. Sohail, 2007, Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections, J Am Coll Cardiol, 49, 1851, 10.1016/j.jacc.2007.01.072 · DOI · Paper page

Cited by

See all 302

Metadata

Authors
Duray, G. Z., Ritter, P., El-Chami, M., Narasimhan, C., Omar, R., Tolosana, J. M., Zhang, S., Soejima, K., Steinwender, C., Rapallini, L., Cicic, A., Fagan, D. H., Liu, S., & Reynolds, D.
Venue
Heart Rhythm
Publisher
Elsevier BV
Published
2017-05
Volume
14
Issue
5
Pages
702-709
ISSN
1547-5271 (ISSN-L)
OpenAlex
W2587560734
Cited by
302
References
3
FWCI
22.83
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. https://app.cochat.ai/papers/10.1016/j.hrthm.2017.01.035
The paper
Duray, G. Z., Ritter, P., El-Chami, M., Narasimhan, C., Omar, R., Tolosana, J. M., Zhang, S., Soejima, K., Steinwender, C., Rapallini, L., Cicic, A., Fagan, D. H., Liu, S., & Reynolds, D. (2017). Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2017.01.035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.